Suprelorin

Country: European Union

Language: Portuguese

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

acetato de deslorelina

Available from:

Virbac S.A.

ATC code:

QH01CA93

INN (International Name):

deslorelin acetate

Therapeutic group:

Dogs; Ferrets

Therapeutic area:

Hormonas e análises pituitárias e hipotalâmicas

Therapeutic indications:

Para a indução de infertilidade temporária em cães e ferrets saudáveis, inteiros, maduros e maduros.

Product summary:

Revision: 13

Authorization status:

Autorizado

Authorization date:

2007-07-10

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Está disponível informação atualizada sobre este medicamento
veterinário no sítio Web de Informação
sobre Medicamentos Veterinários.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Está disponível informação atualizada sobre este medicamento
veterinário no sítio Web de Informação
sobre Medicamentos Veterinários.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 15-02-2024
Public Assessment Report Public Assessment Report Bulgarian 21-07-2013
Patient Information leaflet Patient Information leaflet Spanish 15-02-2024
Public Assessment Report Public Assessment Report Spanish 21-07-2013
Patient Information leaflet Patient Information leaflet Czech 15-02-2024
Public Assessment Report Public Assessment Report Czech 21-07-2013
Patient Information leaflet Patient Information leaflet Danish 15-02-2024
Public Assessment Report Public Assessment Report Danish 21-07-2013
Patient Information leaflet Patient Information leaflet German 15-02-2024
Public Assessment Report Public Assessment Report German 21-07-2013
Patient Information leaflet Patient Information leaflet Estonian 15-02-2024
Public Assessment Report Public Assessment Report Estonian 21-07-2013
Patient Information leaflet Patient Information leaflet Greek 15-02-2024
Public Assessment Report Public Assessment Report Greek 21-07-2013
Patient Information leaflet Patient Information leaflet English 15-02-2024
Public Assessment Report Public Assessment Report English 21-07-2013
Patient Information leaflet Patient Information leaflet French 15-02-2024
Public Assessment Report Public Assessment Report French 21-07-2013
Patient Information leaflet Patient Information leaflet Italian 15-02-2024
Public Assessment Report Public Assessment Report Italian 21-07-2013
Patient Information leaflet Patient Information leaflet Latvian 15-02-2024
Public Assessment Report Public Assessment Report Latvian 21-07-2013
Patient Information leaflet Patient Information leaflet Lithuanian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 15-02-2024
Public Assessment Report Public Assessment Report Lithuanian 21-07-2013
Patient Information leaflet Patient Information leaflet Hungarian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 15-02-2024
Public Assessment Report Public Assessment Report Hungarian 21-07-2013
Patient Information leaflet Patient Information leaflet Maltese 15-02-2024
Public Assessment Report Public Assessment Report Maltese 21-07-2013
Patient Information leaflet Patient Information leaflet Dutch 15-02-2024
Public Assessment Report Public Assessment Report Dutch 21-07-2013
Patient Information leaflet Patient Information leaflet Polish 15-02-2024
Public Assessment Report Public Assessment Report Polish 21-07-2013
Patient Information leaflet Patient Information leaflet Romanian 15-02-2024
Public Assessment Report Public Assessment Report Romanian 21-07-2013
Patient Information leaflet Patient Information leaflet Slovak 15-02-2024
Public Assessment Report Public Assessment Report Slovak 21-07-2013
Patient Information leaflet Patient Information leaflet Slovenian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 15-02-2024
Public Assessment Report Public Assessment Report Slovenian 21-07-2013
Patient Information leaflet Patient Information leaflet Finnish 15-02-2024
Public Assessment Report Public Assessment Report Finnish 21-07-2013
Patient Information leaflet Patient Information leaflet Swedish 15-02-2024
Public Assessment Report Public Assessment Report Swedish 21-07-2013
Patient Information leaflet Patient Information leaflet Norwegian 15-02-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 15-02-2024
Patient Information leaflet Patient Information leaflet Icelandic 15-02-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 15-02-2024
Patient Information leaflet Patient Information leaflet Croatian 15-02-2024

Search alerts related to this product

View documents history